Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.081 | 0.7 |